This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Sciinov Group, a global event producer by its division Siconnects brings a distinguished conference on COVID-19. We are excited to announce the “4th Edition of Global Congress on COVID-19” which is going to be held Virtually during March 13th, 2023.
The main theme of the congress is “Research & Challenges”
COVID-19 Webinar is launched to recognise the urgent need to analyse research, review policy and exchange frontline experiences related to the COVID-19 pandemic. This conference with a special focus on prevention will feature the latest prevention related science, policy and practice. The conference will take place virtually and will include invited-speaker session...
Will be bringing you the latest scientific research, clinical best practice and an opportunity to network
We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables. If you are interested in being considered as a speaker please reach us through https://siconnects.com/covid19/contact.php
Yes, registration is mandate to join the conference. You can register for the conference via https://siconnects.com/covid19/registration.php
There are four different session formats. They are:
Yes; there are a limited number of press passes for the event.
We can tailor a partnership package to help meet your business objectives. This might include brand awareness, driving traffic to your site or quality editorial content via exclusive interviews and Q&As with our executive audience. Enquire today for more information.
Mar
2022
WHO launches guidance on digitally documenting SARS-CoV-2 test results
Test Result technical specifications and guidance document for countries and implementing partnersReadmore
Mar
2022
If granted, Nuvaxovidâ„¢ COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged 12-17 years in EuropeReadmore
Mar
2022
The partnership will accelerate stockpiling, channel distribution and regional access of the amubarvimab/romlusevimab combinationReadmore
Mar
2022
Second booster dose is intended to offer increased protection against severe disease and hospitalization for individuals who are most vulnerableReadmore
.jpg.jpg)
.jpg.jpg)
Recruiting well-known and larger-scale speakers for the main topics
Good opportunity to deepen our knowledge at the current pandemic.
Global
The global market for COVID-19 diagnostic services is valued at $60.3 billion in 2020. The market should grow from $84.4 billion in 2021 to $195.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% during 2021-2027.
Global
Wholesale Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global wholesale market as it emerges from the COVID-19 shut down.
Global
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Covid-19 Vaccine Market Report The global COVID-19 vaccine market by revenue is expected to reach a value of USD 5 billion during 2021-2024.
Global
This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present.
.jpeg.jpeg)
.jpeg.jpeg)
